C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates TUCSON, Ariz., May 12, 2021 — Criti
C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy devel
C-Path Selects New Leaders of Data Science and Quantitative Medicine TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data
C-Path Opens Access to Duchenne Regulatory Science Consortium Database Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystr
C-Path’s Alzheimer’s Disease Consortium Expands Data Repository New patient-level data will facilitate more efficient clinical trial design TUCSON, Ariz., April 12, 2021 — The Critical Path In
C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.
C-Path Receives FDA Qualification for the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the
C-Path and Global Partners Launch Ataxia Consortium The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias TUCSON, Ariz., Febru